Venture capitalist Chamath Palihapitiya has filed to list a SPAC worth $250 million under the name of American Exceptionalism ...

Discover LifeMD's Q2 performance with slowed revenue growth, revised 2025 guidance, and concerns over margins.

Grab's growth prospects, cash position, and limited Western competition justify its higher price-to-sales ratio. See why GRAB ...

For 2Q25, the Macquarie Small Cap Value Fund Institutional Class shares outpaced its benchmark, the Russell 2000 Value Index.

Discover why China Yuchai (CYD) is poised for growth in 2025 and beyond with strong market share gains, trade-in incentives, ...

Aave dropped sharply to $288 after a failed attempt to reclaim the $335 resistance zone earlier this week. The breakdown from ...

Discover why Pentair's premium valuation is justified with strong margins, strategic acquisitions, and dividend aristocrat ...

Hamilton Lane has always been more of an investment solutions provider with management capabilities than a pure-play operator ...

Fabrinet's (FN) stock fell premarket on Tuesday despite fourth quarter results and fiscal first quarter outlook beating estimates.